Coronavirus: VIR CEO on partnering with GSK to develop treatments, vaccines

(6:10)

GSK-Vir drug works against Omicron, according to new data

(54)

Vir Biotech CEO on the expanded GSK partnership

(4:37)

Omicron: GSK-Vir drug effective against COVID-19 variant, U.S. changes international travel rules

(1:34)

VIR, GSK begin Phase 3 trial for Covid-19 antibody drug

(1:5)

GSK-Vir drug works against Omicron — data

(1:4)

GSK chief scientist and Vir CEO on clinical trial for Covid-19 antibody drug

(5:39)

RSVP to Life’s Important Moments: Contracting RSV

(5:14)

How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others

(11:49)

35 years of RTS,S | The world’s first malaria vaccine for endemic countries

(4:45)

From Our Experts: Monoclonal Antibodies | What They Are and How They Fight COVID-19

(6:17)

How is synthetic biology revolutionising vaccines?

(1:47)

Supporting health equity in HIV prevention, treatment and care

(3:46)

Meet Tammeka, a change maker, innovator and equality advocate, working to end HIV

(1:14)

ETL Speaker Series: George Scangos, Vir Biotechnology

(47:49)

Skip Virgin: \

(1:2:7)

GlaxoSmithKline and Vir start phase 2/3 study for Covid-19 antibody drug

(2:5)

Coronavirus treatment: Glaxosmithkline partners with Vir to start antibody treatment tests

(1:49)

USFDA Junks Authorization of GSK Vir COVID Therapy Sotrovimab

(1:37)

U.S. FDA gives emergency use approval for GSK-Vir COVID-19 antibody drug | ANC

(3:37)

Sotrovimab COVID (VIR-7831) GSK,Emergency Use Authorization by FDA

(4:23)

Vir CEO: Omicron Is Probably Not the Last Variant

(5:7)

GSK says tests hint COVID drug fights Omicron

(1:37)

GSK and Vir Biotechnology collaboration to find coronavirus solutions

(1:45)

GSK says tests hint Covid-19 drug fights Omicron

(1:47)

Sotrovimab - Xevudy

(5:16)

GSK \u0026 Vir’s Monoclonal Antibody Covid Treatment Gets Emergency

(1:59)

GSK actions to support the global response to COVID-19

(4:16)

GSK lacking 'focused investment on R\u0026D,' says European pharmaceuticals analyst

(3:4)